检索

期
标题
作者
卷 16, 编号 1 (2024)
Secondary hyperparathyroidism in patients with chronic kidney disease in Tyumen region: five-year follow-up data
Avdeeva V., Syachina S., Eirich V., Zhmurov D., Zhmurov V.
PDF
(Rus)
卷 15, 编号 1 (2023)
Participation of fibroblast factor 23 in the development of acute myocardial infarction in patients with chronic kidney disease
Mambetova A., Gaturaeva S., Semenova I.
PDF
(Rus)
编号 1 (2016)
Chronic kidney disease and hyperparathyroidism: primary and/or secondary? (a case report)
Vetchinnikova O., Britvin T., Gulimova S.
PDF
(Rus)
编号 5-6 (2015)
Prevalence, course and opportunities for correction of secondary hyperparathyroidism in dialysis patients
Gerasimchuk R., Novokshonov K., Zemchenkov A.
PDF
(Rus)
编号 4 (2012)
Parikal'tsitol - novye vozmozhnosti optimizatsii nefroprotektivnoy strategii i lecheniya vtorichnogo giperparatireoza
Plotnikova A., Milovanova L., Milovanov Y.
PDF
(Rus)
编号 2 (2012)
Selective activation VDR - pioneering approach to prevention and treatment of secondary hyperpara-thyreoidism, cardio- and renoprotecton
Shilo V., Shilo V.
编号 1 (2014)
Therapeutic tactics in tertiary hyperparathyroidism after renal transplantation (Review and clinical observations)
Vetchinnikova O., Kantariya R.
PDF
(Rus)
编号 5 (2011)
New opportunities in treatment of secondary hyperparathyreoidism in patients on program haemodialysis with combination of cinacalcet and low doses of low doses of vitamin D sterols
Shutov E., Lashutin S., Lyuosev V., Ryabinskaya G., Gorelova E., Levankovskaya E.
卷 14, 编号 1 (2022)
Calcimimetics in the treatment of secondary hyperparathyroisis in dialysis patients: comparison of the efficacy and safety of cinacalcet and etelcalcetide
Volgina G.
PDF
(Rus)
编号 2 (2014)
The results of the advisory council of experts «Place of calcimimetics in modern clinical recommendations for mbd-ckd - in the light of new studies using cincalcet»
Zemchenkov A.
PDF
(Rus)
编号 4 (2011)
Use of cinacalcet in children with chronic kidney disease stage V
Molchanova M., Petrosyan E., Pankratenko T., Zverev D., Rumyantsev A., Bykova L., Gracheva L.
卷 13, 编号 2 (2021)
Efficacy and safety of etelcalcetide compared with cinacalcet in patients received hemodialysis with secondary hyperparathyroidism. Results from a prospective randomized trial
Shutov E., Kotlyarova G., Lysenko K., Ryabinskaya G., Lashutin S., Markelova I., Rubleva S.
PDF
(Rus)
编号 6 (2013)
Early treatment with phosphate-binders and active metabolites of vitamin D in prevention of secondary hyperparathyreoidism in patients with chronic kidney disease on program hemodialysis
Milovanova L., Plotnikova A., Milovanov Y., Dobrosmyslov I., Anashkin V., Ilinih E., Yagupova T.
PDF
(Rus)
卷 13, 编号 3 (2021)
Risk factors for development of severe hypocalciemia after paratyreoidectomy for secondary hyperparathyroidisis in dialysis patients
Kislyy P., Parshina E., Zulkarnaev A., Tolkach A., Mikhailova S., Chernikov R., Zarya Y.
PDF
(Rus)
编号 1 (2013)
Therapeutic tactics in persistent and recurrent secondary (renal) hyperparathyroidism
Vetchinnikova O., Zakharova N.
PDF
(Rus)
卷 12, 编号 2 (2020)
Ethelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients: a review of clinical data and a place in therapy
Volgina G., Mikhailova N.
PDF
(Rus)
编号 4 (2013)
Hyperphosphatemia in patients with chronic kidney disease in hemodyalisis: risks and opportunities of correction
Zemchenkov A., Gerasimchuk R., Vishnevskii K., Zemchenkov G.
PDF
(Rus)
编号 1 (2019)
Early stages of CKD: problems and prospects
Dorofeeva E.
PDF
(Rus)
编号 1 (2013)
Secondary hyperparathyreoidism in chronic kidney disease. Role of fibroblast growth factor-23 (FGF-23) and Klotho
Milovanova L., Milovanov Y., Dobrosmislov I.
PDF
(Rus)
1 - 19 的 19 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##